FDA
Raltegravir Potassium
The FDA lists this product in 2 strengths and forms.
Composition
- Active ingredients
- RALTEGRAVIR POTASSIUM EQ 400MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RALTEGRAVIR POTASSIUM EQ 400MG BASE · TabletThis page
- RALTEGRAVIR POTASSIUM EQ 600MG BASE · TabletANDA217990-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA203540.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Raltegravir Potassium
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hetero Labs LTD III
- Status
- Discontinued
- FDA approval
- 19 Dec 2024
- Application
- ANDA203540-001